๐ Week recap: Reddit $RDDT craters 21%, Novo Nordisk $NVO -9.4% โ Friday carnage
Friday was rough for two big names: Reddit ($RDDT) plunged 21% โ its worst single-day drop since its IPO โ despite smashing Q2 earnings ($805M revenue, EPS $1.25 vs $0.95 expected), as investors punished zero new AI licensing deals and "choppy" Google search referrals. Novo Nordisk ($NVO) shed 9.4% after its cardiovascular drug ziltivekimab flopped the late-stage Zeus trial โ hit the right biomarker but failed to cut actual heart attacks and strokes, ending a 3-month winning streak. The broader market brushed it all off โ Nasdaq closed the week up ~1% and the S&P 500 settled at 7,490. Not financial advice. Is either of these a buy-the-dip setup or is the selling justified?